Company: HURA
Filing Date: 2025-08-12
Form Type: S-1
Source: 0001193125-25-179009
Chunk: 393

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-08-12
Form: S-1
Chunk 393
---
 185 |   |     |       |    200 |   |
| Insurance and Other             |     |             |                           68 |     |                | 1,055 |     |       |  1,123 |     |             |                           58 |     |                |  1,356 |   |     |       |  1,414 |   |
| Research and development—Direct |     |             |                        4,255 |     |                |     — |     |       |  4,255 |     |             |                        6,782 |     |                |      — |   |     |       |  6,782 |   |
| Office Expenses                 |     |             |                           19 |     |                |   268 |     |       |    287 |     |             |                           51 |     |                |    323 |   |     |       |    374 |   |
| Taxes                           |     |             |                            — |     |                |     1 |     |       |      1 |     |             |                            9 |     |                |   (352 | ) |     |       |   (343 | ) |
| Depreciation                    |     |             |                            — |     |                |     — |     |       |      — |     |             |                            — |     |                |      9 |   |     |       |      9 |   |
| Total operating expenses        |     | $           |                        5,387 |     | $              | 8,145 |     | $     | 13,532 |     | $           |                        9,023 |     | $              | 12,142 |   |     | $     | 21,165 |   |

F-143

#### KINETA, INC.

### Notes to Consolidated Financial Statements

#### Entity-Wide Disclosures
In addition to the segment information, the Company provides entity-wide disclosures about its products and services, geographic areas, and major customers. The Company did not generate revenue for the year ended December 31, 2024 and generated license and collaboration revenue from one customer located in the United States for the year ended December 31, 2023.

The Company currently operates only in the United States and there were no long-lived assets outside of the United States as of December 31, 2024 and 2023